Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1/2 1

Status

Recruiting 3Unknown 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Dermatologic 1

Conditions

Warts 2Hyperthermia 2Breast Neoplasms 2Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Hydrogen Peroxide × Clear all
NCT07565350 2026-05-04

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

First Hospital of China Medical University

Phase NA Recruiting
80 enrolled

Hyperthermia, Warts

NCT03946202 2026-03-27

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

Institute of Cancer Research, United Kingdom

Phase 2 Recruiting
184 enrolled
Breast

Breast Neoplasms

NCT06812065 2025-02-06

Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts

First Hospital of China Medical University

Phase NA Recruiting
300 enrolled

Hyperthermia, Warts

NCT04929535 2022-08-30

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Unknown
51 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT02757651 2020-11-27

KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response

Institute of Cancer Research, United Kingdom

Phase 1/2 Completed
12 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡